Abstract
Summary: Normal hemostasis depends in part on the balance achieved between proaggregatory and prothrombotic platelet thromboxane A2, measured as its stable end-product thromboxane B2 (TXB2), and vascular prostacyclin (PGI2), which inhibits platelet aggregation and is antithrombotic. Cystathionine-β-synthase deficiency is characterized by a high frequency of thromboembolic disease. We therefore studied, in vitro, the effects of homocysteine and related compounds on platelet TXB2 and vascular PGI2 formation.
In paired samples of platelet rich plasma, which had been preincubated with L-homocystine (1 mM), mean production of the two platelet cyclooxygenase products, TXB2 and 12-hydroxy-5,8,10-heptadecatrienoic acid increased significantly from control levels [13.6% ± 1.9 to 19.8% ± 2.1 (P < 0.02) TXB2 and 29.8% ± 4.2 to 39.4% ± 4.1 (P < 0.01) HHT]. In the presence of D.L-homocysteine (1 mM), mean platelet TXB2 and 12-hydroxy-5,8,10-heptadecatrienoic acid production was also significantly increased [12.7% ± 1.5 to 16.9% ± 1.5 (P < 0.01) TXB2 and 27% ± 4 to 31% ± 4.1 (P < 0.02) HHT]. Cystine, cysteine, or methionine (1 mM) did not have similar effects in this test system. Homocysteine and homocystine were without effect on the synthesis of vascular PGI2 by umbilical artery segments [control, 0.22 ± 0.03 to 0.21 ± 0.03 ng/mg with D.L-homocysteine and 0.20 ± 0.04 control to 0.19 ± 0.04 ng/mg with D.L-homocystine]. A homocyst(e)ine-induced increase in platelet thromboxane production in the absence of an increase in vascular prostacyclin, if present in vivo, may contribute to the vascular thromboses characteristic of human homocystinemias (homocystinurias).
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Graeber, J., Slott, J., Ulane, R. et al. Effect of Homocysteine and Homocystine on Platelet and Vascular Arachidonic Acid Metabolism. Pediatr Res 16, 490–493 (1982). https://doi.org/10.1203/00006450-198206000-00018
Issue Date:
DOI: https://doi.org/10.1203/00006450-198206000-00018
This article is cited by
-
Homocysteine, a risk factor for cardiovascular disease
International Journal of Angiology (2011)
-
Chronic methionine load-induced hyperhomocysteinemia impairs the relaxation induced by bradykinin in the isolated rat carotid
Amino Acids (2009)
-
Homocysteine: Role and implications in atherosclerosis
Current Atherosclerosis Reports (2006)
-
Impaired Homocysteine Metabolism and Atherothrombotic Disease
Laboratory Investigation (2001)
-
Blood levels of homocysteine and atherosclerotic vascular disease
Current Atherosclerosis Reports (2000)